Hj. Hammers et al., Ultraviolet-induced detection of halogenated pyrimidines: Simultaneous analysis of DNA replication and cellular markers, CYTOMETRY, 40(4), 2000, pp. 327-335
Background: We describe a new nonenzymatic method ology that allows the sim
ultaneous detection of DNA replication and other cellular markers such as i
mmunophenotyping. DNA replicating cells are identified by their incorporati
on of halogenated thymidine analogs, e.g., 5-bromo-deoxyuridine (BrdUrd).
Methods: Irradiation with ultraviolet (UV)-B or UV-A light in the presence
of Hoechst 33258 and subsequent treatment with a hypotonic buffer makes Brd
Urd accessible to monoclonal antibodies (mAb), thus allowing its sensitive
detection.
Results: The photolysis of BrdUrd in DNA with UV light is sequence dependen
t and results in DNA damage, allowing the detection of remaining BrdUrd usi
ng hypotonic conditions. However, treatment with other inducers of single o
r double- strand breaks of DNA such as gamma irradiation or hydrogen peroxi
de did not allow BrdUrd detection. The new methodology is compatible with b
oth mild crosslinking fixation, i.e., aldehydes, or coagulative fixation, i
.e., alcohols. The successful identification of CD34+, CD138+, or CD19+ cel
ls out of heterogeneous cell suspensions and their cell-cycle analysis are
described. Results correlated very well with acid denaturation (r = 0.972).
The average coefficient of variation (CV) of G(1) in the DNA histogram was
smaller than 5%, resulting in good preservation of DNA distribution. Also,
the signal-to-noise ratio was almost twice as high as for 2N acid denatura
tion, facilitating convenient discrimination of BrdUrd-positive cells.
Conclusions: In contrast to previous approaches, this methodology eliminate
s the need for anp additional enzymatic treatment such as DNA digestion or
strand-break labeling after UV irradiation. The method is fast, convenient,
and inexpensive and should be able to promote the use of halogenated pyrim
idines in basic and clinical research of cancer, immunology, and pharmacolo
gy. (C) 2000 Wiley Liss, Inc.